Published in JAMA on July 02, 2003
Social relationships and mortality risk: a meta-analytic review. PLoS Med (2010) 10.37
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation (2010) 4.50
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ (2012) 4.23
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes (2009) 2.53
Health effects of light and intermittent smoking: a review. Circulation (2010) 2.46
Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42
Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc (2009) 1.88
Strategies to help a smoker who is struggling to quit. JAMA (2012) 1.68
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health (2005) 1.57
Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study. Hypertension (2014) 1.54
Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health (2009) 1.51
Association of smoking status with health-related outcomes after percutaneous coronary intervention. Circ Cardiovasc Interv (2015) 1.48
Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health (2006) 1.43
PURLs: Counseling is a must with this smoking cessation aid. J Fam Pract (2012) 1.38
Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One (2010) 1.32
Mortality after acute myocardial infarction according to income and education. J Epidemiol Community Health (2006) 1.20
Chronic medical conditions and risk of sepsis. PLoS One (2012) 1.16
A system dynamics model for planning cardiovascular disease interventions. Am J Public Health (2010) 1.14
The QUIT-PRIMO provider-patient Internet-delivered smoking cessation referral intervention: a cluster-randomized comparative effectiveness trial: study protocol. Implement Sci (2010) 1.13
Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys. BMJ Open (2011) 1.10
Promoting smoking cessation during hospitalization for coronary artery disease. Can J Cardiol (2006) 1.10
Cardiac rehabilitation past, present and future: an overview. Cardiovasc Diagn Ther (2012) 1.09
Review of electronic decision-support tools for diabetes care: a viable option for low- and middle-income countries? J Diabetes Sci Technol (2011) 1.08
Femoral artery occlusion increases expression of ASIC3 in dorsal root ganglion neurons. Am J Physiol Heart Circ Physiol (2010) 1.08
A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease. PLoS Med (2010) 1.06
The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. BMC Public Health (2009) 1.05
Diabetes & coronary heart disease: current perspectives. Indian J Med Res (2010) 1.03
Varenicline in the treatment of tobacco dependence. Neuropsychiatr Dis Treat (2008) 1.03
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation (2013) 1.02
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology (2012) 1.01
Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc (2009) 1.00
Development of an interactive, Web-delivered system to increase provider-patient engagement in smoking cessation. J Med Internet Res (2011) 0.98
Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction. BMJ (2004) 0.98
Modifiable determinants of hearing impairment in adults. Prev Med (2011) 0.97
Prevalence of alternative forms of tobacco use in a population of young adult military recruits. Addict Behav (2007) 0.97
Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region. Dtsch Arztebl Int (2012) 0.96
Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study. BMC Cardiovasc Disord (2012) 0.94
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag (2013) 0.94
Secondary prevention in the intensive care unit: does intensive care unit admission represent a "teachable moment?". Crit Care Med (2011) 0.94
Share2Quit: Web-Based Peer-Driven Referrals for Smoking Cessation. JMIR Res Protoc (2013) 0.93
Cigarette smoking, passive smoking, alcohol consumption, and hearing loss. J Assoc Res Otolaryngol (2014) 0.93
Identifying opportunities for a medical group to improve outcomes for patients with coronary artery disease and heart failure: an exploratory study. Perm J (2011) 0.93
Acid-sensing ion channel subtype 3 function and immunolabelling increases in skeletal muscle sensory neurons following femoral artery occlusion. J Physiol (2011) 0.92
Contribution of nerve growth factor to upregulation of P2X₃ expression in DRG neurons of rats with femoral artery occlusion. Am J Physiol Heart Circ Physiol (2011) 0.92
Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison. Neth Heart J (2009) 0.92
Who participates in Web-assisted tobacco interventions? The QUIT-PRIMO and National Dental Practice-Based Research Network Hi-Quit studies. J Med Internet Res (2013) 0.92
Effectiveness of a telephone delivered and a face-to-face delivered counseling intervention for smoking cessation in patients with coronary heart disease: a 6-month follow-up. J Behav Med (2013) 0.90
Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. Am Heart J (2012) 0.89
Adherence to varenicline and abstinence rates for quitting smoking in a private health promotion center-based smoking cessation clinic. Tuberc Respir Dis (Seoul) (2012) 0.89
Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands. Br J Clin Pharmacol (2004) 0.89
Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000. BMC Public Health (2007) 0.88
Living healthier for longer: comparative effects of three heart-healthy behaviors on life expectancy with and without cardiovascular disease. BMC Public Health (2009) 0.87
Muscle afferent receptors engaged in augmented sympathetic responsiveness in peripheral artery disease. Front Physiol (2012) 0.87
Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease. J Epidemiol Community Health (2005) 0.87
Mortality after myocardial infarction: impact of gender and smoking status. Eur J Epidemiol (2011) 0.86
Smoking and cardiac rehabilitation participation: Associations with referral, attendance and adherence. Prev Med (2015) 0.86
Web-based peer-driven chain referrals for smoking cessation. Stud Health Technol Inform (2013) 0.86
Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial. Trials (2012) 0.86
Is there any association between use of smokeless tobacco products and coronary heart disease in Bangladesh? PLoS One (2012) 0.86
The association of income with health behavior change and disease monitoring among patients with chronic disease. PLoS One (2014) 0.86
Bradykinin B2 receptor contributes to the exaggerated muscle mechanoreflex in rats with femoral artery occlusion. Am J Physiol Heart Circ Physiol (2013) 0.85
Role for NGF in augmented sympathetic nerve response to activation of mechanically and metabolically sensitive muscle afferents in rats with femoral artery occlusion. J Appl Physiol (1985) (2012) 0.85
Effects of the wars on smoking among veterans. J Gen Intern Med (2010) 0.85
Rehabilitation status three months after first-time myocardial infarction. Scand J Prim Health Care (2011) 0.85
Smoking determines the 10-year (2004-2014) prognosis in patients with Acute Coronary Syndrome: the GREECS observational study. Tob Induc Dis (2015) 0.84
Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations. BMC Cardiovasc Disord (2013) 0.84
Patient characteristics associated with receipt of lifestyle behavior advice. N C Med J (2009) 0.84
Clinical Characteristics and Outcomes of Acute ST-Segment Elevation Myocardial Infarction in Younger Korean Adults. Korean Circ J (2015) 0.84
Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial. PLoS One (2012) 0.83
Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes (2015) 0.83
The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income country. Prev Chronic Dis (2011) 0.83
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association. Circulation (2016) 0.83
Clinician's guide to the updated ABCs of cardiovascular disease prevention. J Am Heart Assoc (2014) 0.82
Risk factors for cardiovascular disease mortality among 86866 members of the Thai Cohort Study, 2005-2010. Glob J Health Sci (2015) 0.82
Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study. J Infect Dis (2016) 0.82
Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk. Heart (2005) 0.82
Augmented P2X response and immunolabeling in dorsal root ganglion neurons innervating skeletal muscle following femoral artery occlusion. J Neurophysiol (2013) 0.82
Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description. BMC Cardiovasc Disord (2012) 0.82
Current Diagnosis and Management of Erectile Dysfunction. Curr Sex Health Rep (2014) 0.82
Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study. J Pediatr (2014) 0.82
Atherosclerosis: current status of prevention and treatment. Int J Angiol (2011) 0.82
Can small changes in cardiovascular risk factors predict large future reductions in coronary heart disease mortality in Ireland? Eur J Epidemiol (2007) 0.81
Impact of cardiovascular calcifications on the detrimental effect of continued smoking on cardiovascular risk in male lung cancer screening participants. PLoS One (2013) 0.81
Decision-making using absolute cardiovascular risk reduction and incremental cost-effectiveness ratios: a case study. Cardiovasc J Afr (2008) 0.81
Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals. Int J Cardiovasc Imaging (2013) 0.81
Preventive effect of varenicline on impairment of endothelial function in cerebral vessels induced by acute smoking in rats. J Anesth (2012) 0.80
Nerve Growth Factor, Muscle Afferent Receptors and Autonomic Responsiveness with Femoral Artery Occlusion. J Mod Physiol Res (2014) 0.80
Prediction of cardiovascular events by using non-vascular findings on routine chest CT. PLoS One (2011) 0.79
Smoking behavior among coronary heart disease patients in Jordan: a model from a developing country. Int J Environ Res Public Health (2010) 0.79
Changes in smoking behavior and adherence to preventive guidelines among smokers after a heart attack. J Geriatr Cardiol (2013) 0.79
Examining Rowe and Kahn's Concept of Successful Aging: Importance of Taking a Life Course Perspective. Gerontologist (2014) 0.79
The risk and burden of smoking related heart disease mortality among young people in the United States. Tob Induc Dis (2015) 0.79
Knowledge of heart disease among women in an urban emergency setting. J Natl Med Assoc (2004) 0.79
Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada. Tob Control (2014) 0.79
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol (2007) 7.13
Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation (2004) 6.46
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ (2011) 3.86
The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail (2002) 3.17
How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation (2008) 3.13
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J (2009) 2.89
Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation (2004) 2.81
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation (2009) 2.60
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59
Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol (2005) 2.43
The use of research evidence in public health decision making processes: systematic review. PLoS One (2011) 2.32
Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. Annu Rev Public Health (2011) 2.24
Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med (2012) 2.07
Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study. BMJ (2009) 2.05
Policy options to reduce population salt intake. BMJ (2011) 1.91
Healthy lifestyle behaviors and all-cause mortality among adults in the United States. Prev Med (2012) 1.87
Trends in the prevalence of low risk factor burden for cardiovascular disease among United States adults. Circulation (2009) 1.83
Remarkable decline in ischemic stroke mortality is not matched by changes in incidence. Stroke (2012) 1.79
Doctors' perceptions of palliative care for heart failure: focus group study. BMJ (2002) 1.73
Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ (2012) 1.69
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health (2005) 1.57
Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet (2013) 1.55
Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health (2009) 1.51
Modelling the impact of a healthy diet on cardiovascular disease and cancer mortality. J Epidemiol Community Health (2010) 1.50
[Analyzing the coronary heart disease mortality decline in a Mediterranean population: Spain 1988-2005]. Rev Esp Cardiol (2011) 1.48
Community care in England: reducing socioeconomic inequalities in heart failure. Circulation (2012) 1.47
Seasonal variation in morbidity and mortality related to atrial fibrillation. Int J Cardiol (2004) 1.46
Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? Heart (2012) 1.45
Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health (2006) 1.43
Persistent socioeconomic inequalities in cardiovascular risk factors in England over 1994-2008: a time-trend analysis of repeated cross-sectional data. BMC Public Health (2012) 1.41
The comparative effectiveness of heart disease prevention and treatment strategies. Am J Prev Med (2009) 1.36
Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One (2010) 1.32
Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline. BMC Public Health (2008) 1.32
Why are patients in clinical trials of heart failure not like those we see in everyday practice? J Clin Epidemiol (2003) 1.31
Coronary heart disease policy models: a systematic review. BMC Public Health (2006) 1.31
Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil (2009) 1.28
Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail (2012) 1.27
Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention. Am J Prev Med (2010) 1.24
What explains declining coronary mortality? Lessons and warnings. Heart (2008) 1.24
The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. Int J Cardiol (2011) 1.23
Heart failure in a cold climate. Seasonal variation in heart failure-related morbidity and mortality. J Am Coll Cardiol (2002) 1.23
Planning ahead in public health? A qualitative study of the time horizons used in public health decision-making. BMC Public Health (2008) 1.21
Quantifying options for reducing coronary heart disease mortality by 2020. Circulation (2013) 1.20
The complex nature of informal care in home-based heart failure management. J Adv Nurs (2008) 1.17
Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality. J Clin Epidemiol (2005) 1.17
Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke (2009) 1.15
Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. J Neurol Neurosurg Psychiatry (2010) 1.13
Doctors' understanding of palliative care. Palliat Med (2006) 1.12
Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. Int J Cardiol (2012) 1.11
Trends in adult cardiovascular disease risk factors and their socio-economic patterning in the Scottish population 1995-2008: cross-sectional surveys. BMJ Open (2011) 1.10
Salt: the dying echoes of the food industry. Am J Hypertens (2013) 1.08
United Nations' dietary policies to prevent cardiovascular disease. BMJ (2011) 1.07
The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. BMC Public Health (2009) 1.05
Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. Bull World Health Organ (2008) 1.05
Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil (2006) 1.04
Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982-2006: an analytical study. PLoS One (2013) 1.04
Effectiveness and safety of chest pain assessment to prevent emergency admissions: ESCAPE cluster randomised trial. BMJ (2007) 1.03
Potential cardiovascular mortality reductions with stricter food policies in the United Kingdom of Great Britain and Northern Ireland. Bull World Health Organ (2012) 1.02
Policy-makers' attitudes to decision support models for coronary heart disease: a qualitative study. J Health Serv Res Policy (2008) 1.02
Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open (2013) 1.01
Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006. Int J Cardiol (2013) 1.00
Population-level changes to promote cardiovascular health. Eur J Prev Cardiol (2012) 1.00
Analyzing recent coronary heart disease mortality trends in Tunisia between 1997 and 2009. PLoS One (2013) 0.99
Continuing decrease in coronary heart disease mortality in Sweden. BMC Cardiovasc Disord (2014) 0.98
Trends in total and low-density lipoprotein cholesterol among U.S. adults: contributions of changes in dietary fat intake and use of cholesterol-lowering medications. PLoS One (2013) 0.98
The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease. Circ Cardiovasc Qual Outcomes (2013) 0.96
Recent UK trends in the unequal burden of coronary heart disease. Heart (2012) 0.96
Modelling coronary heart disease mortality in Northern Ireland between 1987 and 2007: broader lessons for prevention. Eur J Prev Cardiol (2012) 0.96
Trends in longer-term survival following an acute myocardial infarction and prescribing of evidenced-based medications in primary care in the UK from 1991: a longitudinal population-based study. J Epidemiol Community Health (2010) 0.96
Use of evidence to support healthy public policy: a policy effectiveness-feasibility loop. Bull World Health Organ (2012) 0.96
Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)--rationale and methods. Int J Public Health (2012) 0.95
Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. Value Health (2010) 0.95
Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland. Eur J Public Health (2006) 0.94
Health professionals' responses to the introduction of a home telehealth service. J Telemed Telecare (2004) 0.94
Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circ Cardiovasc Qual Outcomes (2009) 0.93
Barriers to partnership working in public health: a qualitative study. PLoS One (2012) 0.90
Ethnic variations in chest pain and angina in men and women: Scottish Ethnicity and Health Linkage Study of 4.65 million people. Eur J Prev Cardiol (2011) 0.90
Prospective cohort studies of coronary heart disease in the UK: a systematic review of past, present and planned studies. J Cardiovasc Risk (2003) 0.89
Associations between deprivation and rates of childhood overweight and obesity in England, 2007-2010: an ecological study. BMJ Open (2012) 0.89
Patient and primary care physician satisfaction with chest pain unit and routine care. Acad Emerg Med (2004) 0.89
Negotiating palliative care expertise in the medical world. Soc Sci Med (2003) 0.88
Myocardial infarction incidence and survival by ethnic group: Scottish Health and Ethnicity Linkage retrospective cohort study. BMJ Open (2013) 0.88
Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000. BMC Public Health (2007) 0.88
Small changes in snacking behaviour: the potential impact on CVD mortality. Public Health Nutr (2008) 0.87
Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health (2013) 0.87
Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006. BMC Public Health (2012) 0.87
How to cut down salt intake in populations. Heart (2010) 0.86
Why choice of metric matters in public health analyses: a case study of the attribution of credit for the decline in coronary heart disease mortality in the US and other populations. BMC Public Health (2012) 0.85
Analysing falls in coronary heart disease mortality in the West Bank between 1998 and 2009. BMJ Open (2012) 0.85
Sugar sweetened drinks should carry obesity warnings. BMJ (2014) 0.85
Quantifying policy options for reducing future coronary heart disease mortality in England: a modelling study. PLoS One (2013) 0.84
Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study. Eur J Cardiovasc Prev Rehabil (2010) 0.84
Young children's food in Liverpool day-care settings: a qualitative study of pre-school nutrition policy and practice. Public Health Nutr (2011) 0.84
The International Diabetes Federation: losing its credibility by partnering with Nestlé? Lancet (2012) 0.84
The Brighton declaration: the value of non-communicable disease modelling in population health sciences. Eur J Epidemiol (2014) 0.84
Trends in cardiovascular disease biomarkers and their socioeconomic patterning among adults in the Scottish population 1995 to 2009: cross-sectional surveys. BMJ Open (2012) 0.84